Revival of TE2A; a better chelate for Cu(II) ions than TETA?

A highly effective synthetic route for TE2A was developed and the (64)Cu-labeled TE2A complexes showed higher kinetic inertness and faster clearance than most commonly used TETA analogs.

[1]  C. Anderson,et al.  Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). , 2009, Accounts of chemical research.

[2]  T. Nayak,et al.  Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges. , 2009, Bioconjugate chemistry.

[3]  Shuang Liu.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. , 2008, Advanced drug delivery reviews.

[4]  Luis M. De Leon-Rodriguez,et al.  The synthesis and chelation chemistry of DOTA-peptide conjugates. , 2008, Bioconjugate chemistry.

[5]  D. W. Price,et al.  Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data. , 2007, Dalton transactions.

[6]  C. Anderson,et al.  The long and short of it: the influence of N-carboxyethyl versusN-carboxymethyl pendant arms on in vitro and in vivo behavior of copper complexes of cross-bridged tetraamine macrocycles. , 2007, Dalton transactions.

[7]  C. Anderson,et al.  Radiolabeling of TETA- and CB-TE2A-conjugated peptides with copper-64 , 2007, Nature Protocols.

[8]  C. Anderson,et al.  Copper chelation chemistry and its role in copper radiopharmaceuticals. , 2007, Current pharmaceutical design.

[9]  L. Zakharov,et al.  Kinetic Inertness and Electrochemical Behavior of Copper(II) Tetraazamacrocyclic Complexes: Possible Implications for in Vivo Stability , 2005 .

[10]  David E Reichert,et al.  Comparative in vivo behavior studies of cyclen-based copper-64 complexes: regioselective synthesis, X-ray structure, radiochemistry, log P, and biodistribution. , 2004, Journal of medicinal chemistry.

[11]  Weijun Niu,et al.  Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. , 2004, Journal of medicinal chemistry.

[12]  A. Bianchi,et al.  Thermodynamic and structural aspects of manganese(II) complexes with polyaminopolycarboxylic ligands based upon 1,4,7,10-tetraazacyclododecane (cyclen). Crystal structure of dimeric [MnL]2·2CH3OH containing the new ligand 1,4,7,10-tetraazacyclododecane-1,4-diacetate , 2001 .

[13]  Daniel C. Hill,et al.  Synthesis and Characterization of Cross-Bridged Cyclams and Pendant-Armed Derivatives and Structural Studies of Their Copper(II) Complexes , 2000 .

[14]  M. Welch,et al.  In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. , 2000, Bioconjugate chemistry.

[15]  M. Welch,et al.  The in vivo behavior of copper-64-labeled azamacrocyclic complexes. , 1998, Nuclear medicine and biology.

[16]  Jurriaan Huskens,et al.  Alkaline Earth Metal and Lanthanide(III) Complexes of Ligands Based upon 1,4,7,10-Tetraazacyclododecane-1,7-bis(acetic acid). , 1997, Inorganic chemistry.

[17]  M. Welch,et al.  Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. , 1996, Bioconjugate chemistry.

[18]  V. Alexander.  Design and Synthesis of Macrocyclic Ligands and Their Complexes of Lanthanides and Actinides , 1995 .

[19]  M. Jennings,et al.  Copper and nickel complexes of 1,8-disubstituted derivatives of 1,4,8,11-tetraazacyclotetradecane , 1992 .

[20]  D. Parker,et al.  General routes for the synthesis of mono, di and tri-n-substituted derivatives of cyclam , 1989 .

[21]  D. Parker,et al.  Selective N,N-functionalisation of cyclam: crystal structure of the Cu2+ complex of 1,4,8,11-tetra-azacyclotetradecane-1,8-diacetic acid and the tricyclic lactam 15,18-dioxo-1,5,8,12-tetra-azatricyclo[10.2.2.25.8]tetradecane , 1988 .